HoSAGE: sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: study protocol for a cohort trial.
Anne-Laure CoudercPatrick VillaniJulie BerbisEmilie NouguerèdeDominique ReyDominique RossiÉric LechevallierDelphine BadinandCyrille BastideGilles KarsentyRomain BoissierKahena AmichiXavier MuracciolePublished in: BMC cancer (2022)
The protocol was registered to the French drug and device regulation agency under the number 2019-A02319-48, before beginning the study (11/12/2019). The ClinicalTrials.gov identifier is NCT04484246, registration on the ClinicalTrials.gov ( https://clinicaltrials.gov/ct2/show/NCT04484246 ).
Keyphrases
- prostate cancer
- risk factors
- community dwelling
- randomized controlled trial
- radical prostatectomy
- clinical trial
- computed tomography
- case report
- skeletal muscle
- phase iii
- magnetic resonance imaging
- contrast enhanced
- phase ii
- magnetic resonance
- image quality
- stem cells
- emergency department
- positron emission tomography
- mesenchymal stem cells
- electronic health record
- drug administration